- Home
- ATMU vs MRUS Comparison
ATMU vs MRUS Comparison
Compare ATMU & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATMU
- MRUS
- Stock Information
- Founded
- ATMU 1958
- MRUS 2003
- Country
- ATMU United States
- MRUS Netherlands
- Employees
- ATMU N/A
- MRUS 260
- Industry
- ATMU Auto Parts:O.E.M.
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- ATMU Consumer Discretionary
- MRUS Health Care
- Exchange
- ATMU Nasdaq
- MRUS Nasdaq
- Market Cap
- ATMU 2.8B
- MRUS 3.5B
- IPO Year
- ATMU 2023
- MRUS 2016
- Fundamental
- Price
- ATMU $36.21
- MRUS $58.53
- Analyst Decision
- ATMU Buy
- MRUS Strong Buy
- Analyst Count
- ATMU 5
- MRUS 15
- Target Price
- ATMU $42.40
- MRUS $88.87
- AVG Volume (30 Days)
- ATMU 730.4K
- MRUS 1.7M
- Earning Date
- ATMU 05-02-2025
- MRUS 05-07-2025
- Dividend Yield
- ATMU 0.42%
- MRUS N/A
- EPS Growth
- ATMU 13.25
- MRUS N/A
- EPS
- ATMU 2.22
- MRUS N/A
- Revenue
- ATMU $1,659,500,000.00
- MRUS $54,732,000.00
- Revenue This Year
- ATMU $2.90
- MRUS $39.00
- Revenue Next Year
- ATMU $5.01
- MRUS $7.48
- P/E Ratio
- ATMU $16.22
- MRUS N/A
- Revenue Growth
- ATMU 1.43
- MRUS 42.77
- 52 Week Low
- ATMU $27.62
- MRUS $33.19
- 52 Week High
- ATMU $45.43
- MRUS $61.28
- Technical
- Relative Strength Index (RSI)
- ATMU 47.46
- MRUS 69.34
- Support Level
- ATMU $36.07
- MRUS $49.46
- Resistance Level
- ATMU $37.31
- MRUS $56.74
- Average True Range (ATR)
- ATMU 0.80
- MRUS 3.51
- MACD
- ATMU -0.24
- MRUS 1.72
- Stochastic Oscillator
- ATMU 19.07
- MRUS 96.96
About ATMU Atmus Filtration Technologies Inc.
Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. It designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products for first-fit and aftermarket applications including air filters, fuel filters, fuel water separators, lube filters, hydraulic filters, coolants, fuel additives, and other filtration systems to original equipment manufacturers, dealers/distributors, and end-users.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.